Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 01-Mar-23 4:09 PM View:  | Uniqure N.V. (QURE) | 27-Feb-23 | Market Sale | 389 | $19.71 | $7,667.19 | (2%) 16.46K to 16.07K | 1% |
| 24-Jan-23 4:00 PM View: | Mirati Therapeutics, Inc. (MRTX) | 20-Jan-23 | Grant | 89,379 | -- | -- | 145% 61.79K to 151.17K | |
| 19-Jan-23 9:45 AM View: | Mirati Therapeutics, Inc. (MRTX) | 17-Jan-23 | Sale | 3,179 | $42.38 | $134,715.00 | (5%) 64.97K to 61.79K | |
| 21-Dec-22 9:20 PM View: | Mirati Therapeutics, Inc. (MRTX) | 21-Dec-22 | Sale | 4,616 | $40.41 | $186,552.00 | (7%) 69.59K to 64.97K | |
| 21-Dec-22 9:20 PM View: | Mirati Therapeutics, Inc. (MRTX) | 19-Dec-22 | Grant | 35,425 | -- | -- | 104% 34.16K to 69.59K | |
| 11-Jul-22 4:07 PM View: | Entasis Therapeutics Holdin... (ETTX) | 11-Jul-22 | Disposition | 27,500 | $2.20 | $60,500.00 | (100%) 27.5K to 0 | |
| 11-Jul-22 4:07 PM View: | Entasis Therapeutics Holdin... (ETTX) | 07-Jul-22 | Disposition (change in control) | 22,000 | $2.20 | $48,400.00 | (100%) 22.0K to 0 | |
| 17-Jun-22 4:22 PM View: | Uniqure N.V. (QURE) | 15-Jun-22 | Grant | 9,080 | -- | -- | 123% 7.38K to 16.46K | |
| 02-Mar-22 5:34 PM View: | Uniqure N.V. (QURE) | 28-Feb-22 | Sale | 602 | $16.70 | $10,053.40 | (8%) 7.98K to 7.38K | |
| 28-Feb-22 6:27 PM View: | Uniqure N.V. (QURE) | 24-Feb-22 | Grant | 1,534 | -- | -- | 24% 6.45K to 7.98K | |
| 19-Jan-22 4:01 PM View: | Entasis Therapeutics Holdin... (ETTX) | 18-Jan-22 | Grant | 27,500 | -- | -- | 125% 22.0K to 49.5K | |
| 18-Jan-22 6:20 PM View: | Mirati Therapeutics, Inc. (MRTX) | 14-Jan-22 | Grant | 34,057 | -- | -- | 100% 0 to 34.06K | |
| 02-Apr-21 10:34 AM View: | Entasis Therapeutics Holdin... (ETTX) | 01-Apr-21 | Grant | 22,000 | -- | -- | 100% 0 to 22.0K | |
| 04-Mar-21 1:58 PM View: | Uniqure N.V. (QURE) | 02-Mar-21 | Market Sale | 505 | $37.50 | $18,937.50 | (7%) 6.95K to 6.45K | 7% |
| 01-Mar-21 4:00 PM View: | Uniqure N.V. (QURE) | 25-Feb-21 | Grant | 2,382 | -- | -- | 52% 4.57K to 6.95K | |
| 02-Mar-20 3:54 PM View: | Uniqure N.V. (QURE) | 27-Feb-20 | Grant | 2,063 | -- | -- | 82% 2.51K to 4.57K | |
| 30-Jan-20 8:54 PM View: | Uniqure N.V. (QURE) | 28-Jan-20 | Market Sale | 722 | $62.19 | $44,903.40 | (22%) 3.23K to 2.51K | 39% |
| 29-Jan-19 8:01 PM View: | Uniqure N.V. (QURE) | 25-Jan-19 | Grant | 3,230 | -- | -- | 100% 0 to 3.23K | |
| 07-Jun-16 4:29 PM View: | Baxalta Inc (BXLT) | 03-Jun-16 | Disposition | 51,640 | -- | -- | (100%) 51.64K to 0 | |
| 07-Mar-16 6:17 PM View: | Baxalta Inc (BXLT) | 03-Mar-16 | Grant | 27,976 | -- | -- | 114% 24.54K to 52.51K | |
| 07-Mar-16 6:17 PM View: | Baxalta Inc (BXLT) | 03-Mar-16 | Payment of Exercise | 928 | $39.30 | $36,470.40 | (2%) 52.51K to 51.59K | (18%) |
| 04-Sep-15 4:11 PM View: | Baxalta Inc (BXLT) | 02-Sep-15 | Payment of Exercise | 791 | $35.03 | $27,708.70 | (3%) 25.07K to 24.28K | (32%) |
| 06-Jul-15 8:34 PM View: | Baxalta Inc (BXLT) | 01-Jul-15 | Acquisition (other) | 25,068 | -- | -- | 100% 0 to 25.07K | |
| 10-Feb-14 6:30 PM View: | Endocyte, Inc. (ECYT) | 06-Feb-14 | Grant | 7,500 | -- | -- | 100% 0 to 7.5K | |
| 16-Sep-13 7:55 PM View: | Endocyte, Inc. (ECYT) | 12-Sep-13 | Option Exercise | 10,000 | $8.73 | $87,300.00 | 100% 0 to 10.0K | |
| 16-Sep-13 7:55 PM View: | Endocyte, Inc. (ECYT) | 12-Sep-13 | Market Option Sale | 10,000 | $15.50 | $155,000.00 | (100%) 10.0K to 0 | (56%) |